Cargando…

Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia

IMPORTANCE: Although concerns exist regarding a potential increased risk of cardiovascular events for smoking cessation pharmacotherapies, there is general consensus that any increased risk associated with their use would be outweighed by the benefits of smoking cessation; thus, clinical guidelines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Havard, Alys, Choi, Stephanie K. Y., Pearson, Sallie-Anne, Chow, Clara K., Tran, Duong T., Filion, Kristian B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630569/ https://www.ncbi.nlm.nih.gov/pubmed/34842922 http://dx.doi.org/10.1001/jamanetworkopen.2021.36372

Ejemplares similares

Algorithm for resolving discrepancies between claims for smoking cessation pharmacotherapies during pregnancy and smoking status in delivery records: The impact on estimates of utilisation
por: Roper, Lucinda, et al.
Publicado: (2018)

Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study
por: Tran, Duong Thuy, et al.
Publicado: (2020)

Pharmacotherapy of smoking cessation
por: Jiloha, R. C.
Publicado: (2014)

Multiple Pharmacotherapy Adaptations for Smoking Cessation Based on Treatment Response in Black Adults Who Smoke: A Randomized Clinical Trial
por: Nollen, Nicole L., et al.
Publicado: (2023)

Optimal use of smoking cessation pharmacotherapy
por: Mendelsohn, Colin
Publicado: (2022)

Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial
por: Nollen, Nicole L., et al.
Publicado: (2021)

Tobacco policy reform and population-wide antismoking activities in Australia: the impact on smoking during pregnancy
por: Havard, Alys, et al.
Publicado: (2018)

Review of pharmacotherapy for smoking cessation in patients with schizophrenia
por: Shawen, Avery E., et al.
Publicado: (2018)

Data cleaning and management protocols for linked perinatal research data: a good practice example from the Smoking MUMS (Maternal Use of Medications and Safety) Study
por: Tran, Duong Thuy, et al.
Publicado: (2017)

Characterizing Participant Perceptions about Smoking-Cessation Pharmacotherapy and E-Cigarettes from Facebook Smoking-Cessation Support Groups
por: Lee, Allison, et al.
Publicado: (2022)

Algorithms for assessing person-based consistency among linked records for the investigation of maternal use of medications and safety
por: Tran, Duong, et al.
Publicado: (2017)

Examination of the mechanism of action of two pre-quit pharmacotherapies for smoking cessation
por: Ferguson, Stuart G., et al.
Publicado: (2015)

Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy
por: Truong, Van Thi Thanh, et al.
Publicado: (2023)

U Can't Touch This With Pharmacotherapy Alone for Weight Loss or Smoking Cessation
por: Curtiss, Frederic R.
Publicado: (2005)

Association of Maternal Cigarette Smoking and Smoking Cessation With Preterm Birth
por: Soneji, Samir, et al.
Publicado: (2019)

Gender difference and effect of pharmacotherapy: findings from a smoking cessation service
por: Walker, N. J., et al.
Publicado: (2016)

Smoking Cessation Pharmacotherapy Utilization and Costs to a Medicaid Managed Care Plan
por: Corelli, Robin L., et al.
Publicado: (2021)

Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders
por: Taylor, Gemma M J, et al.
Publicado: (2019)

Comparison of Prescribing Patterns Before and After Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2019)

Association between duration of use of pharmacotherapy and smoking cessation: findings from a national survey
por: Siahpush, Mohammad, et al.
Publicado: (2015)

Cost-effectiveness of Implementing Smoking Cessation Interventions for Patients With Cancer
por: Levy, Douglas E., et al.
Publicado: (2022)

The Smoking MUMS (Maternal Use of Medications and Safety) Study: protocol for a population-based cohort study using linked administrative data
por: Havard, Alys, et al.
Publicado: (2013)

Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial
por: Russo, Cristina, et al.
Publicado: (2022)

Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active‐ and placebo‐controlled EAGLES trial
por: Ayers, Catherine R., et al.
Publicado: (2019)

Effectiveness of pharmacotherapy for smoking cessation: protocol for umbrella review and quality assessment of systematic reviews
por: Melka, Alemu S., et al.
Publicado: (2018)

Erratum to: Gender difference and effect of pharmacotherapy: findings from a smoking cessation service
por: Walker, N. J., et al.
Publicado: (2017)

Incentives for Smoking Cessation During Pregnancy: An Ethical Framework
por: Breunis, Leonieke J, et al.
Publicado: (2019)

Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients
por: Hall, Sharon M, et al.
Publicado: (2018)

Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)
por: Lin, Jialing, et al.
Publicado: (2023)

Agreement of acute serious events recorded across datasets using linked Australian general practice, hospital, emergency department and death data: implications for research and surveillance
por: Ahmed, Sarah, et al.
Publicado: (2023)

Association of a Comprehensive Smoking Cessation Program With Smoking Abstinence Among Patients With Cancer
por: Cinciripini, Paul M., et al.
Publicado: (2019)

Monitoring the Increase in the U.S. Smoking Cessation Rate and Its Implication for Future Smoking Prevalence
por: Méndez, David, et al.
Publicado: (2022)

Cardiovascular risk of smoking and benefits of smoking cessation
por: Gallucci, Giuseppina, et al.
Publicado: (2020)

Interest in and Use of Smoking Cessation Support Across Pregnancy and Postpartum
por: Naughton, Felix, et al.
Publicado: (2019)

An Open Trial of Metacognitive Remediation Therapy and Pharmacotherapy to Promote Smoking Cessation among Individuals with Psychotic-Spectrum Disorders
por: Breitborde, Nicholas J. K., et al.
Publicado: (2021)

Association Between Smoking, Smoking Cessation, and Mortality by Race, Ethnicity, and Sex Among US Adults
por: Thomson, Blake, et al.
Publicado: (2022)

An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts
por: Bader, P, et al.
Publicado: (2009)

Inequalities in the Impact of National Reimbursement of Smoking Cessation Pharmacotherapy and the Influence of Injunctive Norms: An Explorative Study
por: Benson, Fiona E., et al.
Publicado: (2016)

Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders
por: Talukder, Saki Rubaiya, et al.
Publicado: (2023)

Pharmacotherapy in Tobacco Cessation: A Narrative Review
por: Pajai, Devanjali D, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jpg136eb1obnj968dm201fdg82